Lv2
178 积分 2026-04-28 加入
Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world study
3个月前
已完结
Safety and tolerability of regorafenib: a real-life experience
3个月前
已完结
The efficacy of erythrocyte apheresis for treatment of secondary erythrocytosis: An observational study
3个月前
已完结
The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
3个月前
已完结
Evidence-based approach to management of hepatic encephalopathy in adults
3个月前
已完结
Ammonia in liver diseases: A glimpse into the controversies and consensus
3个月前
已完结
Time course of regorafenib-associated adverse events in the phase III CORRECT study
4个月前
已关闭
PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)
4个月前
已完结
Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
4个月前
已完结
Inter‐Ethnic Differences in the Efficacy and Safety of Tyrosine Kinase Inhibitors Used in Oncology: Insights From Phase 3 Clinical Trials
4个月前
已关闭
皖公网安备34019202002308
